Cholinesterase inhibitors should not be prescribed for mild cognitive impairment
Authors:
- 30 January 2014
- journal article
- editorial
- Published by BMJ in BMJ Evidence-Based Medicine
- Vol. 19 (3) , 101
Abstract
Cholinesterase inhibitors should not be prescribed for mild cognitive impairment Citation for published version: Russ, TC 2014, 'Cholinesterase inhibitors should not be prescribed for mild cognitive impairment ' Evidence-based medicine, vol 19, no. 3, pp. 101., 10.1136/eb-2013-10168Keywords
This publication has 6 references indexed in Scilit:
- Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysisCanadian Medical Association Journal, 2013
- Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementiaAlzheimer's & Dementia, 2012
- Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s diseaseEuropean Archives of Psychiatry and Clinical Neuroscience, 2009
- Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised TrialsPLOS Medicine, 2007
- Frequency of Stages of Alzheimer-Related Lesions in Different Age CategoriesNeurobiology of Aging, 1997